Stocks ended higher on Wall Street Wednesday, bringing the S&P 500 to the brink of another record high. The benchmark index climbed 0.4% for its sixth gain in a row.
Anthem and Abbott Laboratories helped lead gains among health care stocks after turning in solid quarterly earnings reports. Netflix fell after forecasting earnings for its current quarter that were below analysts’ estimates.
The price of Bitcoin rose above $66,000 for the first time.
On Wednesday:
The S&P 500 rose 16.56 points, or 0.4%, to 4,536.19.
The Dow Jones Industrial Average rose 152.03 points, or 0.4%, to 35,609.34.
The Nasdaq fell 7.41 points, or less than 0.1%, to 15,121.68.
The Russell 2000 index of smaller companies rose 13.85 points, or 0.6%, to 2,289.77.
For the week:
The S&P 500 is up 64.82 points, or 1.5%.
The Dow is up 314.58 points, or 0.9%.
The Nasdaq is up 224.34 points, or 1.5%.
The Russell 2000 is up 24.11 points, or 1.1%.
For the year:
The S&P 500 is up 780.12 points, or 20.8%.
The Dow is up 5,002.86 points, or 16.3%.
The Nasdaq is up 2,233.40 points, or 17.3%.
The Russell 2000 is up 314.91 points, or 15.9%.
Before you consider Abbott Laboratories, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Abbott Laboratories wasn't on the list.
While Abbott Laboratories currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
